Acute-on-Chronic Liver Failure: The Role of Precipitating Illness

Abstract

Acute-on-chronic liver failure (ACLF) is a complex syndrome that develops in patients with cirrhosis at any stage during the natural history of the disease. In most cases, the development of ACLF is associated with an identifiable precipitating factor. Overall, the most common precipitating events are bacterial infections. Although data suggest that any type of infection may trigger ACLF, spontaneous bacterial peritonitis, secondary peritonitis, and pneumonia appear to be the most common types of infection leading to ACLF. Nevertheless, frequency and characteristics of precipitating factors differ among geographical areas. Although in the West the most common precipitating factors are bacterial infections followed by active alcoholism, in the East the most common triggering events are exacerbation of hepatitis B virus followed by bacterial infections. Although precipitating events may be crucial in the development of ACLF, mortality appears to be independent of the type of precipitating factor. Finally, it should be noted that in up to 20 to 40% of patients with ACLF no precipitating factor can be identified. It is suggested that in these patients, bacterial products derived from bacterial translocation or damage-associated molecular patterns resulting from injured liver tissue cells may act as triggering factors.

Keywords

acute-on-chronic liver failure - precipitating factors - bacterial infections - cirrhosis - hepatitis B virus

• References

• 1 Moreau R, Jalan R, Ginès P , et al; CANONIC Study Investigators of the EASL–CLIF Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144 (7) 1426-1437 , 1437.e1–1437.e9
• 2 Arroyo V, Moreau R, Jalan R, Ginès P ; EASL-CLIF Consortium CANONIC Study. Acute-on-chronic liver failure: a new syndrome that will re-classify cirrhosis. J Hepatol 2015; 62 (1, Suppl): S131-S143
• 3 Bernal W, Jalan R, Quaglia A, Simpson K, Wendon J, Burroughs A. Acute-on-chronic liver failure. Lancet 2015; 386 (10003) 1576-1587
• 4 Jalan R, Yurdaydin C, Bajaj JS , et al; World Gastroenterology Organization Working Party. Toward an improved definition of acute-on-chronic liver failure. Gastroenterology 2014; 147 (1) 4-10
• 5 Shi Y, Yang Y, Hu Y , et al. Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults. Hepatology 2015; 62 (1) 232-242
• 6 Bajaj JS. Defining acute-on-chronic liver failure: will East and West ever meet?. Gastroenterology 2013; 144 (7) 1337-1339
• 7 Sarin SK, Kumar A, Almeida JA , et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2009; 3 (1) 269-282
• 8 Li H, Pavesi M, Zeng B, Chen LY, Li ST, Qui DK , et al. “Eastern” type of acute-on-chronic liver failure (ACLF) is similar in pathophysiologic, diagnostic and prognostic criteria to the “Western” type: a comparison of Chinese hospitalized patients with hepatitis B with CANONIC data. Hepatology 2014; 60 (Suppl S1): 480A-481A
• 9 Kubes P, Mehal WZ. Sterile inflammation in the liver. Gastroenterology 2012; 143 (5) 1158-1172
• 10 Adebayo D, Morabito V, Andreola F , et al. Mechanism of cell death in acute-on-chronic liver failure: a clinico-pathologic-biomarker study. Liver Int 2015; 35 (12) 2564-2574
• 11 Li H, Xia Q, Zeng B , et al. Submassive hepatic necrosis distinguishes HBV-associated acute on chronic liver failure from cirrhotic patients with acute decompensation. J Hepatol 2015; 63 (1) 50-59
• 12 Hamid SS, Atiq M, Shehzad F , et al. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology 2002; 36 (2) 474-478
• 13 Kumar Acharya S, Kumar Sharma P, Singh R , et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol 2007; 46 (3) 387-394
• 14 Ramachandran J, Eapen CE, Kang G , et al. Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. J Gastroenterol Hepatol 2004; 19 (2) 134-138
• 15 Kumar A, Aggarwal R, Naik SR, Saraswat V, Ghoshal UC, Naik S. Hepatitis E virus is responsible for decompensation of chronic liver disease in an endemic region. Indian J Gastroenterol 2004; 23 (2) 59-62
• 16 Gustot T, Durand F, Lebrec D, Vincent JL, Moreau R. Severe sepsis in cirrhosis. Hepatology 2009; 50 (6) 2022-2033
• 17 Fernández J, Gustot T. Management of bacterial infections in cirrhosis. J Hepatol 2012; 56 (Suppl. 01) S1-S12
• 18 Arvaniti V, D'Amico G, Fede G , et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 2010; 139 (4) 1246-1256 , 1256.e1–1256.e5
• 19 Jalan R, Fernández J, Wiest R , et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol 2014; 60 (6) 1310-1324
• 20 Follo A, Llovet JM, Navasa M , et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 1994; 20 (6) 1495-1501
• 21 Navasa M, Follo A, Filella X , et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 1998; 27 (5) 1227-1232
• 22 Sort P, Navasa M, Arroyo V , et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341 (6) 403-409
• 23 Terra C, Guevara M, Torre A , et al. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterology 2005; 129 (6) 1944-1953
• 24 Fernández J, Acevedo J, Castro M , et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology 2012; 55 (5) 1551-1561
• 25 Bernardi M, Moreau R, Angeli P, Schnabl B, Arroyo V. Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis. J Hepatol 2015; 63 (5) 1272-1284
• 26 Sriskandan S, Altmann DM. The immunology of sepsis. J Pathol 2008; 214 (2) 211-223
• 27 Devière J, Content J, Denys C , et al. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology 1990; 11 (4) 628-634
• 28 Medzhitov R, Schneider DS, Soares MP. Disease tolerance as a defense strategy. Science 2012; 335 (6071) 936-941
• 29 Wiest R, Lawson M, Geuking M. Pathological bacterial translocation in liver cirrhosis. J Hepatol 2014; 60 (1) 197-209
• 30 Albillos A, Lario M, Álvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol 2014; 61 (6) 1385-1396